Parithera

Therapeutics
Founded in 1/1/21
Lausanne, Vaud, Switzerland
http://www.parithera.com
For Profit

About Parithera

Precision oncology includes new ways of treating cancer such as targeted therapies and immunotherapies. These approaches are more specific and effective than current treatments. In the near future, they will considerably reduce worldwide cancer burden. As of today, only a fraction of the 18 million yearly diagnosed patients benefit from precision oncology. To increase the number of beneficiaries, new diagnostic tools are needed to match the specific needs of precision oncology to define patients' eligibility and monitor treatment response.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 100000 CHF
  • Last Funding: 100000 CHF (Grant)
  • Funding Status:

Technology Stack

Parithera actively uses None products in their tech stack.

Market Presence

Industries: Therapeutics

Headquarters: Lausanne, Vaud, Switzerland

Leadership

Employees

  • Antoine Herzog - Chief Executive Officer (LinkedIn)